tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CLRB Stock Latest News

Merck, Regeneron, Cellectar, Humacyte, Foot Locker: Trending by Analysts
Weekend UpdatesMerck, Regeneron, Cellectar, Humacyte, Foot Locker: Trending by Analysts
1d ago
FL
MRK
Cellectar Biosciences Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Cellectar Biosciences Earnings Call: Progress Amid Challenges
2d ago
CLRB
Cellectar Biosciences downgraded to Hold from Buy at Maxim
PremiumThe Fly
Cellectar Biosciences downgraded to Hold from Buy at Maxim
4d ago
CLRB
Cellectar Biosciences Reports Q1 2025 Financials and Strategic Plans
PremiumCompany Announcements
Cellectar Biosciences Reports Q1 2025 Financials and Strategic Plans
4d ago
CLRB
Cellectar Biosciences reports Q1 EPS (14c), consensus (16c)
PremiumThe Fly
Cellectar Biosciences reports Q1 EPS (14c), consensus (16c)
5d ago
CLRB
Cellectar Biosciences expects cash to fund operations in Q4 of 2025
PremiumThe FlyCellectar Biosciences expects cash to fund operations in Q4 of 2025
5d ago
CLRB
CLRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CLRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
13d ago
CLRB
Cellectar Biosciences announces plan to explore strategic alternatives
Premium
The Fly
Cellectar Biosciences announces plan to explore strategic alternatives
18d ago
CLRB
Cellectar Biosciences Enhances CEO and COO Severance Benefits
PremiumCompany Announcements
Cellectar Biosciences Enhances CEO and COO Severance Benefits
2M ago
8K
CLRB
Cellectar Biosciences: Promising Future with FDA Clarity and Innovative Radiopharmaceutical Advancements
PremiumRatings
Cellectar Biosciences: Promising Future with FDA Clarity and Innovative Radiopharmaceutical Advancements
2M ago
CLRB
Cellectar Biosciences Faces Financial and Legal Turmoil Amidst Restated Earnings
PremiumCompany Announcements
Cellectar Biosciences Faces Financial and Legal Turmoil Amidst Restated Earnings
2M ago
CLRB
Cellectar Biosciences Advances Cancer Drug Pipeline
PremiumCompany Announcements
Cellectar Biosciences Advances Cancer Drug Pipeline
2M ago
CLRB
Cellectar Biosciences Earnings Call: Mixed Outlook Amid Successes and Challenges
PremiumCompany AnnouncementsCellectar Biosciences Earnings Call: Mixed Outlook Amid Successes and Challenges
2M ago
CLRB
Cellectar Biosciences reports FY24 EPS ($1.40), consensus ($1.57)
Premium
The Fly
Cellectar Biosciences reports FY24 EPS ($1.40), consensus ($1.57)
2M ago
CLRB
Cellectar Biosciences sees cash runway into 4Q25
Premium
The Fly
Cellectar Biosciences sees cash runway into 4Q25
2M ago
CLRB
CLRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CLRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CLRB
Cellectar Biosciences files to sell 19.22M shares of common stock for holders
PremiumThe Fly
Cellectar Biosciences files to sell 19.22M shares of common stock for holders
4M ago
CLRB
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
ARDX
CGEN
Cellectar Biosciences price target lowered to $1 from $7 at Maxim
PremiumThe Fly
Cellectar Biosciences price target lowered to $1 from $7 at Maxim
5M ago
CLRB
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
ANAB
AUPH
Cellectar Biosciences Strategic Shift and Workforce Reduction
Premium
Company Announcements
Cellectar Biosciences Strategic Shift and Workforce Reduction
5M ago
8K
CLRB
Cellectar Biosciences downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Cellectar Biosciences downgraded to Perform from Outperform at Oppenheimer
5M ago
CLRB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >